Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2001

View Archived Issues

Licensing opportunity from NIH: peptides that stabilize protein antigens

Licensing opportunity from NIH: neutralization site of HEV and use in vaccination

Licensing opportunity from NIH: N-CAM isoforms and psychiatric diseases

Baxter achieves significant R&D milestones during 2000

Oxagen and Incyte partner for gene-based osteoporosis research

Icos reports product pipeline update

Newly designed, highly active SOD mimetic protects against SAO shock

Peripherally administered Ono-8711 reduces postoperative mechanical hyperalgesia in rats

IY-81149 emerges from general pharmacological testing as potentially safe antiulcer drug

Kosan receives NCI grant to improve epothilone production

Caelyx receives approval in Canada for treatment of advanced ovarian cancer

Middle-aged women may reduce stroke risk by consuming more fish

Novel antibacterial substances designed to specifically inhibit bacterial enzymes

Antiinflammatory compounds in development at Abbott inhibit adhesion molecules

Lilly claims new modulators of metabotropic glutamate receptors and their uses

Recent patent covers Lilly's new muscarinic agents

New derivatives of echinocandin and their antifungal activity discussed in recent patents

Nortran's RSD-1235 shows efficacy in canine atrial arrhythmia model

Bradykinin fragment may offer a novel therapeutic strategy for septic shock

Phase II/III trial with OP-2000 for ulcerative colitis initiated

Potential Rx for neuropathic pain enters U.S. phase II trials

Organon licenses Cortex's Ampakines for depression

NIH funds will advance research on HIV vaccines at VaxGen

Nastech begins phase I trial of intranasal interferon alfa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...